Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae691 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Elisabeth Huber und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich 80939, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Diabetes Research, LifeScience-Stiftung, Juvenile Diabetes Research Foundation International.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
Context
Staging and monitoring of presymptomatic type 1 diabetes includes the assessment for dysglycemia.
Objective
To assess the ability of continuous glucose monitoring (CGM) to differentiate between islet autoantibody-negative controls and early-stage type 1 diabetes and explore whether CGM classifiers predict progression to clinical diabetes. Research Design and Methods Children and adolescents participating in public health screening for islet autoantibodies in Bavaria, Germany, were invited to undergo CGM with Dexcom G6. In total, 118 participated and valid data was obtained from 97 [57 female; median age 10 (range 3-17) years], including 46 with stage 1, 18 with stage 2, and 33 with no islet autoantibodies.
Results
Mean glucose during CGM in islet autoantibody-negative controls was high (median, 115.3 mg/dL) and varied substantially (interquartile range, 106.8-124.4). Eleven (33%) of the controls had more than 10% of glucose values above 140 mg/dL (TA140). Using thresholds corresponding to 100% specificity in controls, differences between controls and stage 1 and stage 2 were obtained for glucose SD, TA140, TA160, and TA180. Elevations in any 2 of these parameters identified 12 (67%) with stage 2 and 9 (82%) of 11 participants who developed clinical diabetes within 1 year. However, there was marked variation within groups for all parameters and poor consistency observed in a second CGM performed in 18 participants.
Conclusion
This study demonstrated the potential of integrating CGM into staging and monitoring of early-stage type 1 diabetes. However, substantial improvement in the precision of CGM is required for its application in routine monitoring practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich 80939, Germany.
- Forschergruppe Diabetes at Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich 80939, Germany.
- Faculty of Medicine, Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden 01307, Germany.
- Paul Langerhans Institute Dresden of the Helmholtz Munich at University Hospital Carl Gustav Carus and Faculty of Medicine, TU Dresden, Dresden 01307, Germany.
ORCID-Profile: Elisabeth Huber, Tarini Singh, Melanie Bunk, Mayscha Hebel, Kerstin Kick, Andreas Weiß, Mirjam Kohls, Melanie Köger, Maja Hergl, Jose Maria Zapardiel Gonzalo, Ezio Bonifacio, Anette-G Ziegler
Förderung
- German Center for Diabetes Research
- LifeScience-Stiftung
- Juvenile Diabetes Research Foundation International
- Helmsley Charitable Trust
Zitieren
APA
Huber, E., Singh, T., Bunk, M., Hebel, M., Kick, K., Weiß, A., Kohls, M., Köger, M., Hergl, M., Zapardiel Gonzalo, J. M., Bonifacio, E., & Ziegler, A. G. (2025). Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae691
Vancouver
Huber E, Singh T, Bunk M, Hebel M, Kick K, Weiß A, et al. Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae691
BibTeX
@article{Huber2025,
author = {Huber, Elisabeth and Singh, Tarini and Bunk, Melanie and Hebel, Mayscha and Kick, Kerstin and Weiß, Andreas and Kohls, Mirjam and Köger, Melanie and Hergl, Maja and Zapardiel Gonzalo, Jose Maria and Bonifacio, Ezio and Ziegler, Anette-G},
title = {Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae691}
}
EUVIMED